Tailored scope schedule may cut cancer risk in FAP patients
NCT ID NCT04677998
First seen Feb 20, 2026 · Last updated Jun 23, 2026 · Updated 22 times
Summary
This study tests a personalized surveillance plan for people with familial adenomatous polyposis (FAP), a condition that raises the risk of polyps and cancer in the stomach and duodenum. Participants will have endoscopic exams at intervals tailored to their polyp severity, ranging from every 3 months to every 5 years. The goal is to see if this approach reduces the chance of advanced polyps or cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAMILIAL ADENOMATOUS POLYPOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Academic Medical Centre
RECRUITINGAmsterdam, North Holland, 1105AZ, Netherlands
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MD Anderson
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
personalized surveillance and intervention protocol
What this could lead to
If successful, this could provide a tailored monitoring schedule that reduces the risk of advanced polyps and cancer in people with FAP.
What could go wrong
This is an observational-style study without a control group, so it may not prove the protocol is better than standard care. Results depend on long-term follow-up.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.